itraconazole has been researched along with Esophageal Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (72.73) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chacko, A; Dutta, AK; Esakimuthu, S; Sahni, RD; Sajith, KG | 1 |
| Alcure, ML; Almeida, OP; Bonilha, H; Di Hipólito Júnior, O; Lopes, MA | 1 |
| Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D | 1 |
| Eichel, M; Helm, EB; Just-Nübling, G; Stille, W | 1 |
| Alderman, CP; Allcroft, PD | 1 |
| Darouiche, RO; Laine, L; Mallegol, I; Moskovitz, BL; Wilcox, CM; Wu, J | 1 |
| Cartledge, JD; Gazzard, BG; Midgley, J; Petrou, M; Shanson, D | 1 |
| Esteban Montero, S; Fernández Fernández, A | 1 |
| Darouiche, RO | 1 |
| Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE | 1 |
2 review(s) available for itraconazole and Esophageal Diseases
| Article | Year |
|---|---|
[Itraconazole in systemic fungal infections. Clinical profile and future trends].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Clinical Trials as Topic; Dermatomycoses; Esophageal Diseases; Humans; Itraconazole; Meningitis, Cryptococcal; Mycoses; Pharyngeal Diseases; Tropical Medicine | 1995 |
Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Oropharynx; Pharyngeal Diseases | 1998 |
3 trial(s) available for itraconazole and Esophageal Diseases
| Article | Year |
|---|---|
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles | 2007 |
A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Recurrence; Solutions; Tablets | 1997 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Male; Opportunistic Infections; Recurrence | 1991 |
6 other study(ies) available for itraconazole and Esophageal Diseases
| Article | Year |
|---|---|
Is empiric therapy with fluconazole appropriate for esophageal candidiasis?
Topics: Adult; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged | 2014 |
Oral histoplasmosis in an HIV-negative patient.
Topics: Antifungal Agents; Esophageal Diseases; Histoplasmosis; HIV Seronegativity; Humans; Itraconazole; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Oropharynx; Pharyngeal Diseases | 2006 |
[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Esophagitis; Fluconazole; HIV Infections; Humans; Itraconazole; Retrospective Studies; Suspensions | 1996 |
Digoxin-itraconazole interaction: possible mechanisms.
Topics: Aged; Anti-Arrhythmia Agents; Antifungal Agents; Atrial Fibrillation; Candidiasis; Digoxin; Drug Interactions; Esophageal Diseases; Humans; Itraconazole; Male | 1997 |
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1997 |
Oropharyngeal and esophageal candidiasis in HIV disease: emerging pathogens, changing therapies.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Humans; Itraconazole | 1997 |